Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma.

Saved in:
Bibliographic Details
Title: Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma.
Authors: Stromnes IM; Center for Immunology, University of Minnesota Medical School, Minneapolis, Minnesota. ingunn@umn.edu pgreen@uw.edu srh@fhcrc.org.; Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.; Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, Minnesota., Burrack AL; Center for Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.; Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, Minnesota., Hulbert A; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington., Bonson P; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington., Black C; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington., Brockenbrough JS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Raynor JF; Center for Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.; Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, Minnesota., Spartz EJ; Center for Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.; Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, Minnesota., Pierce RH; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington., Greenberg PD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. ingunn@umn.edu pgreen@uw.edu srh@fhcrc.org.; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, University of Washington School of Medicine, Seattle, Washington., Hingorani SR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. ingunn@umn.edu pgreen@uw.edu srh@fhcrc.org.; Division of Medical Oncology, University of Washington School of Medicine, Seattle, Washington.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Source: Cancer immunology research [Cancer Immunol Res] 2019 Jun; Vol. 7 (6), pp. 977-989. Date of Electronic Publication: 2019 Apr 26.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2326-6074
DOI:10.1158/2326-6066.CIR-18-0448